Depomed, Inc. announced that it has acquired the United States rights to Cambia (diclofenac potassium for oral solution) from Nautilus...
Pozen Inc. announced the acquisition of Tribute Pharmaceuticals Canada Inc., a Canadian specialty pharmaceutical company, in a transaction valued at...